THE MCMANUS GROUP for DENDREON PHARMACEUTICALS LLC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Support for H.R.1826, S.2821 - PSA Screening for HIM Act.
Foreign entity interest: Dendreon is a subsidiary of Nanjing Xinjiekou Department Store, Co. Ltd. in China.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
Medicare/Medicaid MMM
Access to autologous cellular immunotherapies in Medicare Part B. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022
Foreign entity interest: Dendreon is a subsidiary of Nanjing Xinjiekou Department Store, Co. Ltd. in China.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | LA, Bill Thomas. Staff Director, W&M Health Subcommittee |
Taxation/Internal Revenue Code TAX
Issues related to research and development tax amortization in H.R.7024 - Tax Relief for American Families and Workers Act of 2024, S.866 - American Innovation and Jobs Act
Foreign entity interest: Dendreon is a subsidiary of Nanjing Xinjiekou Department Store, Co. Ltd. in China.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.